White House Names RFK Jr. Deputy as CDC Director Replacement

Aug 31, 2025, 8:48 PM
Image for article White House Names RFK Jr. Deputy as CDC Director Replacement

Hover over text to view sources

The White House has appointed Jim O'Neill, deputy to Health Secretary Robert F. Kennedy Jr, as acting director of the Centers for Disease Control and Prevention (CDC) following the abrupt removal of Dr Susan Monarez. The decision comes after Monarez, a former Trump nominee confirmed by the Senate in July, was terminated less than a month into her role due to alleged misalignment with the president’s agenda.
Leadership Shift Amid Controversy, O'Neill, a former Silicon Valley tech investor and HHS deputy secretary since June, will lead the agency at a time of deepening divisions over vaccine policies. His appointment follows the resignation of at least three senior CDC officials, including Chief Medical Officer Debra Houry and National Center for Immunization and Respiratory Diseases director Demetre Daskalakis, who cited frustration with political interference in scientific decision-making.
Legal Battle Over Termination, Monarez’s lawyers argued her firing was illegal, claiming she refused to “rubber-stamp unscientific, reckless directives” and protect dedicated health experts. The White House defended the move, stating Monarez was “not aligned with the president’s agenda” to “make America healthy again.” Kennedy, a vocal vaccine skeptic, framed the CDC as an institution in crisis, accusing it of spreading “misinformation” about public health measures like mask-wearing.
Resignations Signal Institutional Crisis, the exodus of top officials included Jennifer Layden, head of the Office of Public Health Data, and Daniel Jernigan, who resigned after being pressured to revise vaccine safety studies aligned with anti-vaccine narratives. Daskalakis warned that the agency’s new direction posed real risks to public health, stating, “I fear that children will be hurt by poor decision making around vaccines.”.
Political Overreach Concerns, critics including Senator Bernie Sanders condemned the removal of Monarez as “reckless” and “dangerous,” calling for an investigation. The CDC’s leadership vacuum has worsened since Trump took office, with Kennedy purging vaccine advisory boards and cutting funding for medical research. O'Neill’s confirmation hearing in May revealed his support for vaccines but not government mandates, raising questions about his suitability for leading a public health agency.
Legacy of Turmoil, the CDC has faced turmoil since Trump’s election, exacerbated by a deadly shooting at its Atlanta headquarters last month, where a gunman blamed vaccines for his health issues. Monarez’s lawyers argued the administration’s actions risked “weaponizing public health” for political gain, while Kennedy defended reforms as necessary to restore trust in the agency.

Related articles

Federal Government Sues Advocate Aurora Health Over Vaccine Policy

The US Equal Employment Opportunity Commission has filed a lawsuit against Advocate Aurora Health, alleging the health system discriminated against a nurse by denying her a religious exemption from the COVID-19 vaccine mandate. The lawsuit seeks reinstatement, back pay, and changes to the health system's policies.

Kennedy Plans Overhaul of Childhood Vaccine Schedule

Health Secretary Robert F. Kennedy Jr is set to announce a significant overhaul of the childhood vaccination schedule in the US, proposing fewer vaccines in alignment with countries like Denmark. This change has raised concerns among medical experts about potential public health risks and the implications for vaccine accessibility.

Trump Announces New Drug Pricing Deals with Nine Companies

President Trump has announced 'Most Favored Nation' pricing agreements with nine pharmaceutical companies aimed at reducing drug costs for Americans. The agreements will allow Medicaid programs to access lower prices and include plans for a meeting with health insurers to discuss lowering premiums.

Reflecting on America's First COVID Vaccine Five Years Later

Five years ago, the US began its vaccination campaign against COVID-19, marking a pivotal moment in public health. The rapid development and distribution of vaccines, particularly the Pfizer-BioNTech vaccine, showcased unprecedented scientific achievement. As the nation reflects on this milestone, it grapples with the ongoing impacts of the pandemic and the evolving perceptions of vaccines.

FDA Official Proposes Changes to Vaccine Approval Process Amid Claims

An FDA official has announced plans to revise the vaccine approval process, citing alleged links between Covid-19 vaccinations and the deaths of 10 children. The proposed changes aim to enhance safety protocols and require more evidence before vaccines can be authorized.